Tag Archives: The Stem Cell Blog

The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be … – EurekAlert (press release)

Continue reading

2017-06-03 NEWS

Medical Daily

The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be …
EurekAlert (press release)
The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone’s Perlmutter …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »

Continue reading

2017-06-03 NEWS

Medical Daily

Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer
PR Newswire (press release)
NEW YORK, June 3, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug pembrolizumab—already FDA-approved for other forms of cancer–has been found to be effective in patients with metastatic triple negative breast cancer, according to an …
Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New TrialsMedical Daily

all 2 news articles »

Continue reading

2017-06-03 NEWS

Oncology Nurse Advisor

Stem Cell Transplant Patients Benefit From Inpatient Palliative Care
Oncology Nurse Advisor
CHICAGO — Inpatient palliative care integrated with hematopoietic stem cell transplantation (HSCT) care is associated with improvements in depression and symptoms of post-traumatic stress disorder (PTSD) at 6 months after transplantation …

Continue reading

2017-06-03 NEWS

STAT

U.S. could save $825 million a year with a small change in immunotherapy dosing, study says
STAT
That’s the finding of a new study on the immunotherapy drug pembrolizumab, marketed commercially as Keytruda by Merck. By switching to weight-based dosing — instead of a fixed dose of 200 mg — doctors could quickly reduce costs of the intravenous …

Continue reading

2017-06-03 NEWS

Wall Street Pit

CRISPR Found To Have A Dangerous Side-Effect: Unwanted Mutations
Wall Street Pit
People have been calling the CRISPR gene editing technology revolutionary for good reason: there’s no doubt that if used properly, it has the potential to cure many of the world’s worst diseases and medical disorders. And yet the fear that it can be …
Unexpected mutations after CRISPR gene-editingBioEdge

all 2 news articles »